Animal-free lung model unlocks better treatments for RSV in babies
Future therapies for respiratory syncytial virus (RSV) must target both the virus and its immune response to ensure…
Maternal RSV vaccine shows 68% protection against infant RSV hospitalization
A real-world US study finds maternal RSVpreF vaccination may help shield newborns from severe RSV illness during their…
Maternal vaccination provides protection against RSV-associated hospitalization in early infancy
A study led by researchers at the University of Pittsburgh and UPMC published today in JAMA Network Open,…
Singapore becomes first APAC market to approve MSD’s Enflonsia for infant RSV prevention
Singapore becomes first APAC market to approve MSD’s Enflonsia for infant RSV prevention June 2, 2026 | Tuesday…
Major UK clinical trial finds surfactant therapy ineffective for severe bronchiolitis
A major UK-led clinical trial has found that a treatment commonly used to help premature babies breathe offers…
Surge in children with respiratory virus
Hull is facing a surge in respiratory infections in children, a doctor said. Dr Kavitha Tharian, a consultant…
FDA opens safety review of injectable drugs for RSV in kids
WASHINGTON (AP) — Food and Drug Administration officials have opened a safety review of two injectable drugs used…
Early RSV infection turns maternal allergy into a powerful driver of childhood asthma
By combining nationwide health data with elegant immunology experiments, researchers reveal how RSV infection in infancy hijacks maternal…
Respiratory syncytial virus positivity, seasonal trends and risk factors among children under five with acute respiratory infection in Western Democratic Republic of Congo, 2022–2023 | BMC Infectious Diseases
Pruccoli G, Castagno E, Raffaldi I, Denina M, Barisone E, Baroero L, et al. The importance of RSV…
COVID-19, RSV, and flu vaccines remain safe and effective
Backed by real-world evidence from more than 500 studies, a new review shows that this season’s Covid-19, RSV,…